New R&D Center Will Focus on Cell-based Therapies

New R&D Center Will Focus on Cell-based Therapies

302412

New R&D Center Will Focus on Cell-based Therapies

Biopharmaceutical company Brooklyn ImmunoTherapeutics has launched a new center focused on research and development (R&D) of gene editing and cell-based therapies to treat cancer and rare blood disorders, including sickle cell disease. “Our new R&D facility will provide us with the ability to advance our research and development efforts,” Howard J. Federoff, MD, PhD, Brooklyn’s CEO and president, said in a press release. The center, based in Cambridge, Massachusetts, shares a location with biotechnology developers…

You must be logged in to read/download the full post.